SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lilium N.V.

Core Viewpoint - Lilium N.V. is facing legal scrutiny due to allegations of misleading statements regarding its financial health and fundraising efforts, leading to significant stock price declines and potential insolvency [3][4][6]. Group 1: Legal Investigation and Claims - Faruqi & Faruqi, LLP is investigating potential claims against Lilium for investors who suffered losses exceeding $50,000 between June 11, 2024, and November 3, 2024 [1]. - A federal securities class action has been filed against Lilium, with a deadline of January 6, 2025, for investors to seek the role of lead plaintiff [1][7]. Group 2: Allegations Against Lilium - The complaint alleges that Lilium and its executives violated federal securities laws by making false or misleading statements about the company's fundraising progress and financial viability [3]. - Specific allegations include overstating the likelihood of obtaining sufficient funding, failing to disclose imminent insolvency, and providing materially misleading positive statements about the company's operations and prospects [3]. Group 3: Financial Impact and Stock Performance - On October 24, 2024, Lilium disclosed its inability to raise sufficient funds, leading to a stock price drop of $0.33, or 61.6%, closing at $0.21 per share [5]. - The stock continued to decline, falling to $0.15 per share on October 25, 2024, and further to $0.083 per share on November 4, 2024, after announcing that funding was not feasible and insolvency was imminent [5][6]. - By November 5, 2024, the stock price fell to $0.052 per share, marking a total decline of 36.97% from the previous day [6].